The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Enzalutamide in men with chemotherapy-naive metastatic prostate cancer (mCRPC): Results of phase III PREVAIL study.
Tomasz M. Beer
Research Funding - Astellas Pharma; Cougar Biotechnology; Janssen Biotech; Medivation
Andrew J. Armstrong
Consultant or Advisory Role - Bayer; Dendreon; Janssen Biotech; Medivation/Astellas; Sanofi
Honoraria - Dendreon; Sanofi
Research Funding - Active Biotech; Dendreon; Janssen Biotech; Medivation; Sanofi
Cora N. Sternberg
Consultant or Advisory Role - Amgen; Astellas Pharma; Johnson & Johnson; Sanofi
Research Funding - Medivation/Astellas
Celestia S. Higano
Consultant or Advisory Role - Algeta; Amgen; Astellas Pharma; Bayer; BHR Pharma; Dendreon; Endo Pharmaceuticals; Ferring; Genentech; Johnson & Johnson; Medivation; Millennium; Novartis; Oncology Trials Insights; Pfizer; Teva
Research Funding - Aragon Pharmaceuticals; Dendreon; Exelixis; ImClone Systems; Johnson & Johnson; Medivation; Millennium; Oncogenex; Teva
Peter Iversen
Consultant or Advisory Role - Astellas Pharma; Janssen; Medivation
Research Funding - Astellas Pharma; Janssen; Medivation
Yohann Loriot
Research Funding - Astellas Pharma
Dana E. Rathkopf
Research Funding - Astellas Pharma; Medivation
Suman Bhattacharya
Employment or Leadership Position - Medivation
Stock Ownership - Medivation
Joan Carles
Research Funding - Astellas Pharma; Medivation
Johann S. De Bono
Consultant or Advisory Role - Astellas Pharma; AstraZeneca; Medivation; Sanofi
Research Funding - Astellas Pharma; Medivation
Christopher P. Evans
Consultant or Advisory Role - Medivation
Stock Ownership - Medivation
Research Funding - Astellas Pharma; Medivation
Anthony M. Joshua
Research Funding - Astellas Pharma; Medivation
Choung-Soo Kim
Research Funding - Astellas Pharma; Medivation
Go Kimura
Honoraria - Astellas Pharma
Research Funding - Astellas Pharma; Medivation
Paul N. Mainwaring
Consultant or Advisory Role - Janssen; Novartis
Honoraria - Janssen; Novartis; Roche
Research Funding - Astellas Pharma; Medivation
Harry H. Mansbach
Employment or Leadership Position - Medivation
Stock Ownership - Medivation
Kurt Miller
Consultant or Advisory Role - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Dendreon; Ferring; GlaxoSmithKline; Janssen-Cilag; Merck; Novartis; Pfizer; Roche
Research Funding - Astellas Pharma; Medivation; Novartis
Sarah B. Noonberg
Employment or Leadership Position - Medivation
Stock Ownership - Medivation
Peter M. Venner
Consultant or Advisory Role - Astellas Pharma
Research Funding - Astellas Pharma; Medivation
Bertrand Tombal
Consultant or Advisory Role - Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Medivation
Honoraria - Amgen; Bayer; Ferring
Research Funding - Astellas Pharma; Medivation